Schmidt Lab Findings Cited by the Wall Street Journal

“We’re talking about a class of medications that could have efficacy in treating a variety of addictions: cocaine, opioids, nicotine, alcohol, all different addictive drugs with very different pharmacology,” said Heath Schmidt, a neuroscientist studying addiction at the University of Pennsylvania School of Nursing and School of Medicine, who has published studies showing older GLP-1 drugs decrease cocaine, opioid and nicotine use in rodents. Semaglutide may be more potent because it is better than older drugs at reaching the brain, or because it is longer-lasting than older drugs, Schmidt said.”

Check out the rest of the article, Ozempic Might Help You Drink and Smoke Less.